by Mike Masnick on (#5HCMY)
Throughout the COVID pandemic, it's been truly shameful to watch how patent maximalists have tried to insist that we just need more patents to deal with COVID -- even though the incredible breakthroughs that brought such quick development of vaccines were not due to patents, but rather the free and open flow of information from a bunch of researchers and scientists who didn't care about whether or not information was locked up for profit, but did care about saving millions of lives.And now that we've got vaccines, we're dealing with significant problems in rolling them out around the world -- and patents are often in the way, holding that rollout back. And we actually have a way of dealing with that: what's known as a TRIPS waiver. TRIPS is the Agreement on Trade-Related Aspects of Intellectual Property Rights, which set up a variety of standards among member nations and the WTO regarding intellectual property. I have many problems with TRIPS (and the WTO), but TRIPS does include a process to grant waivers on intellectual property rights. This was in response to (very legitimate!) concerns by less well off nations that rich nations would use the patent system to block access to important life saving medicines.So, to ease such concerns, the TRIPS agreement includes a process by which the WTO can grant a compulsory licensing regime that will allow others to make patented drugs, and thus increase availability. A key point of this so-called waiver is that it allows for better allocations of certain drugs during medical emergencies. Given that, issuing such a waiver right now seems like a no-brainer. But... it has not been.India and South Africa put forth a a fairly straightforward waiver request for dealing with COVID-19. The key part of the request is that intellectual property requirements under TRIPS solely in relation to the "prevention, containment or treatment of COVID-19" should be waived during the course of the pandemic. It seems pretty straightforward. Even reliable patent maximalist sites like IP Watchdog are now publishing articles saying that the TRIPS waiver "is a necessary first step towards facilitating increased, rapid production of vaccines" and noting that it won't undermine the value of innovation in any way.We've already noted that Big Pharma is lobbying against it -- which is to be expected. However, what is perhaps less expected is the fact that Hollywood is vehemently lobbying against it as well. Why? Well, they claim that because the waiver is not limited to just patents, it will be used to wipe away copyright as well.This is... misleading at best. It is true that the waiver would cover copyrights, but only in an extremely limited fashion. As the part I quoted above notes, it only applies to intellectual property protections that are blocking the prevention, containment, and treatment of COVID-19. And, that can include a very limited set of copyrights. For example, there still remain shortages of ventilators in many parts of the world, and early on in the pandemic, people were working on 3D printing replacement parts to help deal with this extreme shortage. However, with some companies issuing threats over these 3D printed parts, there are legitimate concerns that copyright could be used to shut down such operations. Another area where a copyright waiver is likely to help is in allowing researchers easier access to important scientific journals and research that may help them develop more and better solutions.As if to make Hollywood calm down, South Africa and India included an explicit statement in the waiver request to say that the waiver cannot be used for entertainment products: "The waiver in paragraph 1 shall not apply to the protection of Performers, Producers of Phonograms (Sound Recordings) and Broadcasting Organizations under Article 14 of the TRIPS Agreement." That's literally the 2nd paragraph in a four paragraph waiver request. Already, it's kind of insulting that officials crafting this waiver request in an attempt to save lives had to waste time making sure that Hollywood wouldn't get angry at them.And even then it didn't work.